New hepatitis C treatment receives Pharmac funding New Zealand Doctor Online "In New Zealand, hepatitis C cirrhosis is now the leading cause of liver cancer and liver failure and is the leading indication for liver transplantation. By offering a better chance of a cure, we can prevent progression to cirrhosis, thereby reducing ... |
